Argan (AGX) Valuation Check After Strong Q4 Earnings Beat And Rising Analyst Optimism

Argan (AGX) has attracted fresh attention after reporting Q4 earnings of $3.47 per share on revenue of $262.1 million, which topped Wall Street estimates and sent the stock sharply higher in recent trading.

See our latest analysis for Argan.

That earnings surprise sits on top of strong recent momentum, with a 90 day share price return of 63.38% and a very large 1 year total shareholder return of 253.80%. This comes even though the stock has pulled back 7.97% over the past day and 2.74% over the past week.

If Argan’s move has you looking for more infrastructure related opportunities, it may be a good time to scan the market using our 35 power grid technology and infrastructure stocks

After such a strong run, Argan’s recent pullback and upbeat quarter raise a key question for you: is the current price fully reflecting its power and infrastructure pipeline, or is there still a genuine buying opportunity here?

Most Popular Narrative: 40.5% Overvalued

Argan’s last close of $664.76 sits well above the most followed fair value estimate of $473.20, putting the focus squarely on what is baked into that gap.

Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully.

Read the complete narrative.

Curious what kind of revenue path, margin profile and future earnings multiple need to line up to defend that valuation gap? The narrative sets out a growth runway built on rising power demand, a sizable project backlog and an earnings multiple that has more in common with high growth stories than typical contractors.

Result: Fair Value of $473.20 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can change quickly if gas heavy projects face faster decarbonization pressure, or if any large EPC contract runs into delays or cost overruns.

Find out about the key risks to this Argan narrative.

Next Steps

With sentiment clearly divided between risks and rewards, it makes sense to look at the full picture yourself and move quickly while the story is fresh. Start by weighing the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Argan has sharpened your focus, do not stop here. Broaden your watchlist with other stocks that fit clear, disciplined criteria using targeted screeners.

• Boost your income shortlist by checking out steady payers in the 12 dividend fortresses.
• Hunt for quality at a reasonable price by scanning the market through the 52 high quality undervalued stocks.
• Focus on financial strength first and shortlist resilient companies via the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com